Will treating diabetes with 11β-HSD1 inhibitors affect the HPA axis?

被引：28
|
作者：
Harno, Erika
White, Anne [1 ]
机构：
[1] Univ Manchester, Acad Hlth Sci Ctr, Fac Life Sci, Manchester M13 9PL, Lancs, England
来源：
TRENDS IN ENDOCRINOLOGY AND METABOLISM | 2010年 / 21卷 / 10期
关键词：
11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; SPLANCHNIC CORTISOL PRODUCTION; PITUITARY-ADRENAL AXIS; DIET-INDUCED OBESITY; METABOLIC SYNDROME; ADIPOSE-TISSUE; VISCERAL OBESITY; MICE; LIVER; MELLITUS;
D O I：
10.1016/j.tem.2010.06.004
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Inhibitors of 11 beta-HSD1 are in clinical trials for the treatment of type 2 diabetes. These compounds act by decreasing the cortisol generated in liver and adipose tissue, and therefore reducing tissue-specific gluconeogenesis and fatty acid metabolism. However, there is concern that reduction in tissue-regenerated cortisol might decrease feedback to the hypothalamic-pituitary-adrenal (HPA) axis, resulting in upregulation of cortisol from the adrenal gland. This review considers evidence from 11 beta-HSD1 knockout and transgenic mice, inhibitor studies and results from clinical trials evaluating HPA axis biomarkers. It is clear that analysis of the HPA axis is not sufficiently detailed, and there is a need to understand the subtle changes in the axis associated with pulsatility, diurnal rhythm and stress.
引用
收藏
页码：619 / 627
页数：9
相关论文
共 50 条
  • [41] 11β-HSD1 is the major regulator of the tissue-specific effects of circulating glucocorticoid excess
    Morgan, Stuart A.
    McCabe, Emma L.
    Gathercole, Laura L.
    Hassan-Smith, Zaki K.
    Larner, Dean P.
    Bujalska, Iwona J.
    Stewart, Paul M.
    Tomlinson, Jeremy W.
    Lavery, Gareth G.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (24) : E2482 - E2491
  • [42] Regulation of Adipocyte 11β-Hydroxysteroid Dehydrogenase Type 1 (11β-HSD1) by CCAAT/Enhancer-Binding Protein (C/EBP) β Isoforms, LIP and LAP
    Esteves, Cristina L.
    Kelly, Val
    Begay, Valerie
    Man, Tak Y.
    Morton, Nicholas M.
    Leutz, Achim
    Seckl, Jonathan R.
    Chapman, Karen E.
    PLOS ONE, 2012, 7 (05):
  • [43] Hupehenols A-E, Selective 11β-Hydroxysteroid Dehydrogenase Type 1 (11β-HSD1) Inhibitors from Viburnum hupehense
    Chen, Xuan-Qin
    Shao, Li-Dong
    Pal, Mahesh
    Shen, Yu
    Cheng, Xiao
    Xu, Gang
    Peng, Li-Yan
    Wang, Kou
    Pan, Zheng-Hong
    Li, Ming-Ming
    Leng, Ying
    He, Juan
    Zhao, Qin-Shi
    JOURNAL OF NATURAL PRODUCTS, 2015, 78 (02): : 330 - 334
  • [44] Progress in 11β-HSD1 inhibitors for the treatment of metabolic diseases: A comprehensive guide to their chemical structure diversity in drug development
    Zhong Chuanxin
    Wang Shengzheng
    Dang Lei
    Xie Duoli
    Liu Jin
    Ren Fuzeng
    Lu Aiping
    Zhang Ge
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 191
  • [45] Time of the day for 11β-HSD1 inhibition plays a role in improving glucose homeostasis in DIO mice
    Veniant, M. M.
    Hale, C.
    Komorowski, R.
    Chen, M. M.
    St Jean, D. J.
    Fotsch, C.
    Wang, M.
    DIABETES OBESITY & METABOLISM, 2009, 11 (02) : 109 - 117
  • [46] Searching for novel applications of the benzohomoadamantane scaffold in medicinal chemistry: Synthesis of novel 11β-HSD1 inhibitors
    Valverde, Elena
    Seira, Constanti
    McBride, Andrew
    Binnie, Margaret
    Luque, F. Javier
    Webster, Scott P.
    Bidon-Chanal, Axel
    Vaquez, Santiago
    BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (24) : 7607 - 7617
  • [47] Potent and novel 11β-HSD1 inhibitors identified from shape and docking based virtual screening
    Xia, Guangxin
    Xue, Mengzhu
    Liu, Lin
    Yu, Jianxin
    Liu, Haiyan
    Li, Ping
    Wang, Jianfa
    Li, Yanlian
    Xiong, Bing
    Shen, Jingkang
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (19) : 5739 - 5744
  • [48] Additive action of 11β-HSD1 inhibition and PPAR-γ agonism on hepatic steatosis and triglyceridemia in diet-induced obese rats
    Berthiaume, M.
    Laplante, M.
    Festuccia, W. T.
    Berger, J. P.
    Thieringer, R.
    Deshaies, Y.
    INTERNATIONAL JOURNAL OF OBESITY, 2009, 33 (05) : 601 - 604
  • [49] Hypothalamic-Pituitary-Adrenal Axis Abnormalities in Response to Deletion of 11β-HSD1 is Strain-Dependent
    Carter, R. N.
    Paterson, J. M.
    Tworowska, U.
    Stenvers, D. J.
    Mullins, J. J.
    Seckl, J. R.
    Holmes, M. C.
    JOURNAL OF NEUROENDOCRINOLOGY, 2009, 21 (11) : 879 - 887
  • [50] 11β- Hydroxysteroid Dehydrogenase Type 1(11β-HSD1) mediates insulin resistance through JNK activation in adipocytes
    Peng, Kesong
    Pan, Yong
    Li, Jieli
    Khan, Zia
    Fan, Mendi
    Yin, Haimin
    Tong, Chao
    Zhao, Yunjie
    Liang, Guang
    Zheng, Chao
    SCIENTIFIC REPORTS, 2016, 6
12345